You Position: Home > Paper

Proteomics analysis of CD133+ and CD133- cells derived from glioma U87 cells

( views:275, downloads:120 )
Author:
No author available
Journal Title:
Chinese Journal of Neurosurgery
Issue:
5
DOI:
10.3760/cma.j.issn.1001-2346.2012.05.017
Key Word:
神经胶质瘤;肿瘤干细胞;蛋白质组学;抗原,CD133;Glioma;Neoplastic stem cells;Proteomies;Antigens,CD133

Abstract: Objective To analyze differences between CD133+ and CD133- glioma U87 cells by methods of proteomics.Methods 2D - PAGE was performed to separate the proteins of the CD133 + and CD133 - U87 cells,which were isolated by magnetic cell sorting.The differential protein spots were analyzed by software analysis,subject to in- gel digestion,and identified by matrix assistant laser desorption time -of - flight mass spectrometry ( MALDI - TOF - MS) and MALDI - TOF/TOF - MS.Results There were 73 differentially expressed protein spots observed in comparing between CD133 + and CD133- U87 cells by 2D -PAGE ( P < 0.05 ).Spots with > 1.5 - fold expression changes were 46,and > 2 - fold were 27,and > 3 -fold were 8.Ten spots were increased,while 63 spots were decreased in CD133 + U87 cells.Forty -four high -quality peptide mass fingerprinting and 35 proteins were obtained by MS. Conclusions There are significant differences between CD133+ and CD133- U87 cells.Differentially proteins have been obtained by proteomics analysis,which are important targets to the study of brain cancer stem cells (BTSCs).

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn